Table 1.
Demographic characteristic of the participants and mean values (±SD) of MetS components in three different groups
| Parameters | Group I (n = 31) | Group II (n = 33) | Group III (n = 36) | P-value |
|---|---|---|---|---|
| Age (years) | 45.4 ± 8.9 | 56.52 ± 12.9 | 63.0 ± 12.1 | <0.0005 |
| Sex (male/female) | 10/21 | 19/14 | 24/12 | — |
| Waist circumference (cm) | 81.16 ± 8.4 | 95.79 ± 13.23 | 110.25 ± 15.46 | <0.0005 |
| Height (cm) | 166.0 ± 9.0 | 167.9 ± 6.2 | 170.8 ± 8.2 | 0.050 |
| Weight (kg) | 67.63 ± 9.27 | 76.25 ± 13.32 | 90.14 ± 16.74 | <0.0005 |
| BMI (kg/m2) | 24.49 ± 2.29 | 27.02 ± 4.66 | 30.89 ± 5.50 | <0.0005 |
| Systolic blood pressure (mm Hg) | 116.2 ± 9.8 | 127.5 ± 15.1 | 142.5 ± 19.1 | <0.0005 |
| Fasting blood glucose (mmol/l) | 6.92 ± 2.64 | 6.06 ± 1.97 | 4.93 ± 0.41 | <0.0005 |
| HDL-C (mmol/l) | 1.45 ± 0.27 | 1.43 ± 0.43 | 1.09 ± 0.22 | <0.0005 |
| Triglyceride (mmol/l) | 1.09 ± 0.34 | 1.37 ± 0.62 | 2.06 ± 0.85 | <0.0005 |
| Current smokers (n) | 1 | 4 | 7 | — |
| Antidiabetic medications | — | 11 | 22 | — |
| Antihypertensive medications | — | 13 | 29 | — |
| Antilipidemic medications | — | 3 | 12 | — |